Form 4 for SGRY Surgery Partners, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-23 · accession 0000899243-22-036913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-23 | 2022-11-23 | SGRY | HENDRIX BLAIR E | Dir, 10% | A - Grant | $24.50 | +9.18M | 58.25M | +19% | +$225.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-23 | A | A | 9,183,673 | $24.50 | 58,248,249 | I See footnote | — | — | (F2) Represents shares of Common Stock held by BCPE Seminole Holdings LP ("BCPE Seminole") and Fund XI. Bain Capital Investors, LLC ("BCI") is the (i) sole member of BCPE Seminole GP LLC, which is the general partner of BCPE Seminole, and (ii) general partner of Bain Capital Partners XI, L.P., which is the general partner of Fund XI. Blair Hendrix is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Hendrix may be deemed to share voting and dispositive power with respect to the securities held by BCPE Seminole and Fund XI. Mr. Hendrix disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |